The short answer
Graf and Kastin reported DSIP-like material across 12 rat tissue areas by radioimmunoassay, ranging from 86 pg/mg in muscle to 849 pg/mg in stomach. Chromatography then showed the immunoreactive material was mostly larger than DSIP itself.
Key facts
- Study
- Graf & Kastin 1984 (PMID 6548030)
- Journal
- Proc Soc Exp Biol Med, October 1984
- Tissues examined
- 12 areas
- Lowest
- 86 pg/mg (muscle)
- Highest
- 849 pg/mg (stomach)
- Chromatography result
- Material mostly larger than DSIP
- After trypsin
- Small immunoreactive peptides appeared
What the study set out to do
DSIP had been reported in brain by radioimmunoassay and immunocytochemistry. Graf and Kastin extended the measurement to peripheral tissue, extracting 12 areas with water and quantifying immunoreactive material in each. Asking whether a supposedly brain-associated peptide appears elsewhere is a reasonable and useful question.
The distribution they found
Immunoreactive material in every area, from 86 pg/mg in muscle to 849 pg/mg in stomach, roughly a tenfold range, with the highest reading in the gastrointestinal tract. For a peptide named after an effect on sleep, the stomach being the richest source is not what the name would lead anyone to expect.
Research material referenced
DSIP 5mg, third-party HPLC tested
The chromatography, which is the important part
They ran the material on Sephadex G-15 and G-25 columns, which separate by size. The immunoreactive material appeared mostly larger than DSIP. So whatever the antibody was binding in these tissues was predominantly not the nine-residue peptide. It was bigger molecules carrying a region the antibody recognised.
What the trypsin experiment adds
Digesting the material with trypsin produced small immunoreactive peptides with only minimal reduction in immunoreactivity. That is consistent with the epitope being contained inside larger molecules and released by cleavage, which is a coherent explanation, and also means the original signal was not measuring free peptide.
Why the title says what it says
The paper is titled DSIP-like material exists in peripheral organs of rats in large dissociable forms. Every element of that is doing work: DSIP-like rather than DSIP, material rather than peptide, and large dissociable forms describing what was actually found. The authors reported the complication rather than burying it.
How this bears on the wider literature
Distribution data is often cited as evidence that an endogenous peptide is real and functionally placed. Where that data comes from immunoassay and the immunoreactive material turns out to be mostly something larger, the inference weakens considerably. This is one reason a fifty-year literature has not consolidated, and it was visible in the primary work from the beginning.
Quick reference
| Observation | What it shows |
|---|---|
| Immunoreactivity in 12 tissues | The antibody bound something everywhere |
| Highest in stomach, 849 pg/mg | Not a brain-restricted distribution |
| Mostly larger by chromatography | Most of it was not DSIP |
| Trypsin releases small fragments | Epitope sits inside larger molecules |
Frequently asked questions
Where was DSIP-like material most abundant?
Stomach, at 849 pg/mg, against a low of 86 pg/mg in muscle across the 12 areas examined.
Was it actually DSIP?
Chromatography showed the immunoreactive material was mostly larger than DSIP, so predominantly not the nine-residue peptide.
What did trypsin digestion show?
It produced small immunoreactive peptides with minimal loss of immunoreactivity. Consistent with the epitope sitting inside larger molecules.
Continue researching
Related guides and reference material.
Primary sources & clinical trials
Published papers, trial registrations, regulator pages and company announcements. Links open the original.
- PubMedGraf MV, Kastin AJ, Delta sleep-inducing peptide (DSIP)-like material exists in peripheral organs of rats in large dissociable forms. Proc Soc Exp Biol Med 1984 (PMID 6548030)pubmed.ncbi.nlm.nih.gov
- PubMedGraf MV, Delta-sleep-inducing peptide (DSIP): an update. Peptides 1986 (PMID 3550726)pubmed.ncbi.nlm.nih.gov
Browse the wider literature
Live database searches, not fixed citations. Results change as new work is indexed.
Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).
Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.
More DSIP (Delta Sleep-Inducing Peptide) articles
- What Adrenalectomy ChangedBjartell 1991 measured immunoreactive DSIP in rat hypothalamus, pituitary and adrenal gland, and examined what removing the adrenals did to it.
- A Question Mark in the Title Is Doing Real WorkGimble 2009 proposed links between DSIP, glucocorticoid-induced leucine zipper, circadian mechanisms and obesity - and framed it as a question.
- What the Field Said After Its First DecadeGraf published a DSIP update in Peptides in 1986. Reading a review from the middle of a literature shows what was expected but never arrived.
- The Barrier Any Central Claim Has to CrossA compound said to act on sleep must reach the brain. The blood-brain barrier excludes most peptides, and getting across is an engineering problem.
- What Is DSIP? The Nonapeptide Named for an EEG EffectDSIP is a nonapeptide isolated from rabbit blood in 1977 and named for an observed EEG effect. No gene, precursor or receptor has ever been identified.